PedAM
Pediatric Disease Annotations & Medicines
| Disease | lupus erythematosus, systemic |
| Symptom | C0007222|cardiovascular disease |
| Sentences | 12 |
| PubMedID- 23052654 | Ambulatory blood pressure and subclinical cardiovascular disease in patients with juvenile-onset systemic lupus erythematosus. |
| PubMedID- 24787906 | Cardiometabolic and immune factors associated with increased common carotid artery intima-media thickness and cardiovascular disease in patients with systemic lupus erythematosus. |
| PubMedID- 24470118 | 25-hydroxyvitamin d and cardiovascular disease in patients with systemic lupus erythematosus: data from a large international inception cohort. |
| PubMedID- 21360503 | Premature cardiovascular disease in patients with systemic lupus erythematosus influences survival after renal transplantation. |
| PubMedID- 22210142 | Premature atherosclerotic cardiovascular disease in systemic lupus erythematosus: understanding management strategies. |
| PubMedID- PMC3467499 | Our study investigates whether serum α-clfa may be a biomarker for subclinical cardiovascular disease (cvd) in patients with systemic lupus erythematosus (sle). |
| PubMedID- 20191526 | Objective: to investigate the association between physical activity, functional activity of high-density lipoprotein (hdl), and subclinical cardiovascular disease in patients with systemic lupus erythematosus (sle). |
| PubMedID- 24658835 | Atherosclerosis and cardiovascular disease in systemic lupus erythematosus: effects of in vivo statin treatment. |
| PubMedID- 23942785 | Increased serum levels of s100a8/a9 and s100a12 are associated with cardiovascular disease in patients with inactive systemic lupus erythematosus. |
| PubMedID- 24790989 | Imbalance between endothelial damage and repair: a gateway to cardiovascular disease in systemic lupus erythematosus. |
| PubMedID- 25732129 | Results: plasma sucrose non-fermenting ampk related kinase and pentraxin 3 concentrations were increased in systemic lupus erythematosus cases with cardiovascular disease compared to systemic lupus erythematosus controls and healthy controls (p < 0.0001). |
| PubMedID- 25379191 | Adverse pregnancy outcomes and subsequent risk of cardiovascular disease in women with systemic lupus erythematosus. |
Page: 1